intellectual property
T2 Biosystems Pathogen Detection Patent Upheld in Europe
French diagnostics maker BioMérieux and other undisclosed firms had filed an opposition to the patent in May 2023.
Top Five Articles on 360Dx Last Week: FDA Warns Agena Bio; Additional Cue Health Data Sought; More
Last week, readers were most interested in a story about a warning letter from FDA to Agena and its implications for clinical labs.
Court Grants Natera Injunction Against Invitae, ArcherDx in Use of Patented Products
The defendants are barred from using Personalized Cancer Monitoring products except for ongoing clinical trials, studies undergoing peer review, and quality control.
Jury Awards Natera $19.4M in Damages in Invitae, ArcherDx Patent Infringement Suit
A jury determined that Invitae and ArcherDx have infringed three patents and awarded Natera damages for lost profits and past royalties.
Pillar Biosciences Licenses KeyGene NGS IP
The intellectual property relates to the use of a combination of two or more nucleotide sequence identifiers in the preparation of a sample DNA for high-throughput sequencing.
Aug 25, 2022
Apr 22, 2019
Enzo, Hologic, Grifols Settle Patent Dispute
Jun 29, 2017
Enzo Patent Found Invalid in Ongoing IP Lawsuits
Jul 15, 2010